{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:22Z","timestamp":1791644602199,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.hpb.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T07:19:41Z","timestamp":1618471181000},"page":"1623-1628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm"],"prefix":"10.1016","volume":"23","author":[{"given":"Hongbeom","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chan Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In W.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonhyeong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin S.","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong W.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Sup","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2021.04.001_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjsurg.2015.03.022","article-title":"Clinical\u00a0significance of preoperative neutrophil\u2013lymphocyte vs platelet\u2013lymphocyte ratio in primary operable patients with non\u2013small cell lung cancer","volume":"210","author":"Zhang","year":"2015","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1245\/s10434-015-4934-0","article-title":"Predictive value of neutrophil\/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer","volume":"23","author":"Asano","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2021.04.001_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.amjsurg.2014.06.014","article-title":"Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer","volume":"209","author":"Graziosi","year":"2015","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hpb.2017.12.009","article-title":"A\u00a0meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection","volume":"20","author":"Mowbray","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2021.04.001_bib5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s11605-008-0554-3","article-title":"Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio","volume":"12","author":"Smith","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib6","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1245\/s10434-012-2348-9","article-title":"The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma","volume":"19","author":"La Torre","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2021.04.001_bib7","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/OTT.S68084","article-title":"A\u00a0new inflammation index is useful for patients with esophageal squamous cell carcinoma","volume":"7","author":"Feng","year":"2014","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.hpb.2021.04.001_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/MPA.0b013e3182954137","article-title":"Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma: invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN","volume":"42","author":"Kang","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2021.04.001_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2021.04.001_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2015.05.062","article-title":"AGA guidelines for the management of pancreatic cysts","volume":"149","author":"Lennon","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2021.04.001_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/gutjnl-2018-316027","article-title":"European evidence-based guidelines on pancreatic cystic neoplasms","volume":"67","author":"ESGoCTot","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2021.04.001_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/SLA.0000000000002015","article-title":"Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: a report from the pancreatic surgery consortium","volume":"267","author":"Attiyeh","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/SLA.0000000000001985","article-title":"Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas","volume":"266","author":"Jang","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11605-015-2973-2","article-title":"The neutrophil-to-lymphocyte ratio predicts malignant potential in intraductal papillary mucinous neoplasms","volume":"19","author":"Arima","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SLA.0000000000001988","article-title":"Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas","volume":"266","author":"Gemenetzis","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MPA.0000000000000271","article-title":"Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma","volume":"44","author":"Ben","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2021.04.001_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jso.23997","article-title":"Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?","volume":"112","author":"Goh","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2021.04.001_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00535-013-0915-x","article-title":"Inflammation and pancreatic cancer: disease promoter and new therapeutic target","volume":"49","author":"Hamada","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.hpb.2021.04.001_bib19","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.3748\/wjg.v20.i32.11160","article-title":"Complex role for the immune system in initiation and progression of pancreatic cancer","volume":"20","author":"Inman","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.hpb.2021.04.001_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1477-2574.2012.00478.x","article-title":"Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response","volume":"14","author":"Huz","year":"2012","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2021.04.001_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"De Visser","year":"2006","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.hpb.2021.04.001_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2011.12.029","article-title":"The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm","volume":"10","author":"Klibansky","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2021.04.001_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005535","article-title":"Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: large-scale, single-center cohort study","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.hpb.2021.04.001_bib24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jamcollsurg.2011.01.016","article-title":"Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period","volume":"212","author":"Gaujoux","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2021.04.001_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X21001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X21001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:34:56Z","timestamp":1761266096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X21001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1365182X21001015"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2021.04.001","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}